US Passes Biosecure Act to Curb Pharma Ties with Chinese Firms
The U.S. House has passed the Biosecure Act, targeting pharmaceutical ties with five Chinese firms, aiming to enhance national security by 2032.
BiosecureAct
Read More
U.S. Legislative Actions Raise Concerns Over Global Competition Stability
U.S. legislative measures like the Biosecure Act targeting Chinese companies raise concerns about the stability of global competition and the future of international trade.
Chinese Authorities Oppose US House Passing Biosecure Act Targeting Biotech Firms
Chinese authorities condemn the US House’s Biosecure Act targeting Chinese biotech firms, citing unfair measures and potential harm to global biosecurity.
US House Kicks Off ‘China Week’ with Over Two Dozen Legislative Proposals
The U.S. House initiates ‘China Week’ with over two dozen bills targeting various economic and security aspects related to China.